Clinical Study to evaluate the Efficacy and Safety of a Dose for Soreness in reducing Muscle Soreness and improving muscle relaxatio
- Registration Number
- CTRI/2024/05/068070
- Lead Sponsor
- Eetho Brands
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1. Male or female subjects between 19 to 60 years of age
2. Adult subjects with good health, as determined by a health history and at the Investigators discretion.
3. Subject willing to participate and able to comply with the protocol.
4. Subjects who provide written, signed, and dated informed consent.
1. Subjects with a sleep disorder or a history of clinical depression, eating disorders, or other psychiatric conditions.
2. Subjects with a history or current presence of health conditions, including abnormal resting ECG, bleeding disorder, diabetes, high blood pressure, thyroid disease, tachyarrhythmia, heart disease, kidney disease, or liver disease.
3. Participants using medications - anti-inflammatory, analgesic, antioxidant drugs, nutritional products, and dietary supplements that may interfere with the study results, as determined by the investigators opinion.
4. History of allergy or sensitivity to any ingredient in the test product, as well as a history of alcohol or other drug abuse within the last year.
5. Participation in another clinical study within the past 30 days.
6. Subjects with a history of orthopaedic injury or surgery within the last year.
7. Presence of any physical condition considered a contraindication to the type of exercise to be performed in the study.
8. Subjects who do not agree to participate or are not capable of complying with protocol requirements.
9. Women who are pregnant or breastfeeding.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method